| ¿µ¹® | rotavirus | ÇÑ±Û | ·ÎŸ¹ÙÀÌ·¯½º |
|---|---|---|---|
| ¼³¸í | ½Ö°¡´Ú RNA ¹ÙÀÌ·¯½ºÀÇ ÀϱºÀ¸·Î¼ ¹ÙÄû¸ð¾çÀÇ ¿Ü°üÀ» °¡Áø´Ù. ÀÌ ¹ÙÀÌ·¯½º´Â âÀÚÀÇ »óÇǼ¼Æ÷¿¡¼ º¹Á¦µÇ°í, ƯÈ÷ ±Þ¼º ¿µ¾Æ À§Ã¢ÀÚ¿°À» ÀÏÀ¸Å²´Ù. ¶ÇÇÑ Áã, ¼Û¾ÆÁö ¹× µÅÁöÀÇ ¼³»ç¸¦ ÀÏÀ¸Å°±âµµ ÇÑ´Ù. »ç¶÷ÀÇ °¨¿°Àº °Ü¿ï¿¡ ÃÖ°íÁ¶¿¡ ´ÞÇÑ´Ù. |
||
| ¿µ¹® | carcinoembryonic antigen | ÇÑ±Û | ¾Ï¹è¾ÆÇ׿ø |
|---|---|---|---|
| ¼³¸í | ¿ø·¡ žÆÀÇ ÀåÁ¶Á÷¿¡¼ Á¤»óÀûÀ¸·Î Á¸ÀçÇÏ´Â ¹°Áú·Î žƱâ ÀÌÈÄ¿¡´Â Á¸ÀçÇÏÁö ¾Ê´Â ¹°ÁúÀÌ´Ù. ±×·¯³ª À§, °£, ÇãÆÄ µîÀÇ ¾ÏÀÌ ÀÖ´Â °æ¿ì¿¡ ¼ºÀο¡¼µµ Á¸ÀçÇÑ´Ù. À̸¦ ÀÌ¿ëÇØ¼ ¾ÏÀÇ Ä¡·áÈ¿°ú ÆÇÁ¤À̳ª Àç¹ß¿©ºÎÀÇ Á¶»ç¿¡ ÀÌ¿ëÇÑ´Ù. |
||
| ¿µ¹® | antigen | ÇÑ±Û | Ç׿ø |
|---|---|---|---|
| ¼³¸í | ƯÀÌÇÑ ¸é¿ª¹ÝÀÀÀ» ÀÏÀ¸Å³ ¼ö ÀÖ´Â ¾î¶°ÇÑ ¹°Áú. ¿©±â¿¡¼ ¸»Çϴ ƯÀÌÇÑ ¸é¿ª¹ÝÀÀÀ̶õ ºñƯÀÌÀûÀÎ ¸é¿ª¹ÝÀÀ°ú´Â ¹Ý´ëµÇ´Â Àǹ̷Π±× ¹°Áú¿¡ ´ëÇØ¼ ƯÀÌÇÏ°Ô ¹ÝÀÀÇÒ ¼ö ÀÖ´Â Ç×ü³ª ±× ¹°Áú¿¡ ´ëÇØ¼ ƯÀÌÇÏ°Ô ¹ÝÀÀÇÒ ¼ö ÀÖ´Â ¼¼Æ÷¸¦ ¸¸µå´Â °ÍÀ» ¸»ÇÑ´Ù. |
||
| ¿µ¹® | test | ÇÑ±Û | °Ë»ç |
|---|---|---|---|
| ¼³¸í | ¾î¶² ´Ù¸¥ ¹°ÁúÀ» °ËÃâ, ÃøÁ¤, »ý¼ºÇϱâ À§ÇÑ Æ¯Á¤ÇÑ ÈÇйÝÀÀÀ» ÀÏÀ¸Å°´Âµ¥ »ç¿ëµÇ´Â ¹æ¹ý. |
||
| ¿µ¹® | scratch test | ÇÑ±Û | ³Àý¹ý |
|---|---|---|---|
| ¼³¸í | ÇǺθ¦ ³¯Ä«·Î¿î ¹Ù´Ã·Î ±Ü¾î ÇǺÎÀÇ ¹ÝÀÀÀ» º¸´Â °Ë»ç·Î ÇǺΠ°ú¹Î¹ÝÀÀÀ̳ª ¾Ë·¹¸£±â¸¦ ¾Ë¾Æº¸±â À§ÇÑ °Ë»çÀÌ´Ù. ¹Ù´Ã³¡¿¡ Ç׿øÀ» ¹¯Èù µÚ, ÇǺιØÀ» ±Ü¾î ¹ÝÀÀÀ» ¾Ë¾Æº»´Ù. À̶§ Ç׿øÀÌ ¾Æ´Ñ ´ëÁ¶¹°Áú(¿¹¸¦ µé¾î º¸ÅëÀÇ ¹°)À» ¹¯Èù ¹Ù´ÃÀ» °°ÀÌ ¹ÝÀÀÇÏ¿© ÇǺ馱âÁõ(dermographism) ´ÜÁö ¹Ù´ÃÀÇ ±ÜÈû¸¸À¸·Î ¾Ë·¹¸£±â °°Àº ¹ÝÀÀÀ» ÀÏÀ¸Å°´Â Çö»ó°ú °¨º°ÇØ¾ß ÇÑ´Ù. ³Ã», û·Â¼Ò½Ç(hearing loss) û°¢ÀÌ ÀúÇÏ ¶Ç´Â »ó½ÇµÈ »óÅÂ. ¿øÀΰú Á¤µµ´Â ¿©·¯ °¡ÁöÀε¥, ³Ã»Àº ±× Á¤µµ°¡ °¡Àå ½ÉÇÑ »óÅÂÀÌ´Ù. û°¢ÀÇ Àüµµ°æ·Î¿¡ Àå¾Ö°¡ ÀÖÀ» ¶§ ³Ã»ÀÌ ÀϾ°í, ±× º´ÅͰ¡ ¿ÜÀ̵µ³ª ÁßÀÌ¿¡ ÀÖ´Â °ÍÀ» ÀüÀ½³Ã», ³»ÀÌ¿¡ ÀÖ´Â °ÍÀ» °¨À½ ³Ã»À̶ó ÇÏ¿© ±¸ºÐÇÑ´Ù. ¶Ç º´ÅÍÀÇ ÀÚ¸®¸¦ ¸í½ÃÇÏ¿© ÁßÀ̼º ³Ã»À̳ª ¹Ì·Î¼º ³Ã» µîÀ¸·Î ¼¼ºÐÇϱ⵵ ÇÑ´Ù. |
||
| HRV | heart rate variability; human reovirus; human rotavirus |
|---|---|
| PAT | Pain Apperception Test; paroxysmal atrial tachycardia; patient; phenylaminotetrazole; physical abili... |
| HLA | histocompatibility leukocyte antigen; histocompatibility locus antigen; homologous leukocyte antibod... |
| TSTA | toxoplasmin skin test antigen; tumor-specific tissue antigen; tumor-specific transplantation antigen... |
| CAT | California Achievement Test; capillary agglutination test; catalase; cataract; catecholamine; Childr... |
| ADRV | Adult Diarrhoea Rotavirus |
|---|---|
| BRV | Bovine rotavirus |
| GBR | group B rotavirus |
| HRV | Human rotavirus |
| RRV | Rhesus rotavirus |
| rotavirus antigen test | <investigation, microbiology> A test which detects the presence of rotavirus in the stool. This virus is a common cause of childhood gastroenteritis. (17 Dec 1997) |
|---|
| rotavirus stool test | <investigation> A test which detects the presence of rotavirus in the stool. This virus is a common cause of childhood gastroenteritis. (17 Dec 1997) |
|---|---|
| Rotavirus | <virology> Genus of the Reoviridae having a double layered capsid and 11 double stranded RNA molecules in the genome. They have a wheel like appearance in the electron microscope and cause acute diarrhoeal disease in their mammalian and avian hosts. Probably the most important cause of severe dehydrating diarrhoea in children under three years of age worldwide. Symptoms include nausea, vomiting, low-grade fever and diarrhoea. Aggressive fluid replacement is generally required. (27 Sep 1997) |
| rotavirus infections | Infection with any of the rotaviruses. Specific infections include human infantile diarrhoea, neonatal calf diarrhoea, and epidemic diarrhoea of infant mice. (12 Dec 1998) |
| aspergillus antigen skin test | <investigation> An antigen, prepared from aspergillus, is injected into the skin. In 48 to 72 hours the site is read as positive or negative. A positive skin test (inflammation at the test site) indicates prior exposure to aspergillus and therefore a risk for developing aspergillosis. (27 Sep 1997) |
| cancer antigen 125 test | Test for cell-surface antigen found on derivatives of coelomic epithelium. Elevated levels of this antigen are associated with ovarian malignancy and benign pelvic disease such as endometriosis. (05 Mar 2000) |
| mumps skin test antigen | A sterile suspension of killed mumps virus in isotonic sodium chloride solution, used to determine susceptibility to mumps or to confirm previous exposure. (05 Mar 2000) |
| acetone-insoluble antigen | A diphosphatidyl glycerol that is found in the membrane of Treponema pallidum and is the antigen detected by the Wasserman test for syphilis. (18 Nov 1997) |
| allogeneic antigen | Genetic variations of the same antigens within a given species. (05 Mar 2000) |
| antigen | Virus coded cell surface antigens that appear soon after the infection of a cell by virus, but before virus replication has begun. See: early gene. (18 Nov 1997) |
| antigen-antibody complex | The complex formed by the binding of antigen and antibody molecules. The deposition of large antigen-antibody complexes leading to tissue damage causes immune complex diseases. If the antigen is polyvalent the complex may be insoluble. Immune complexes activate complement through the classical pathway. See: glomerulonephritis, Arthus reaction, type III hypersensitivity. (12 Dec 1998) |
| antigen-antibody reaction | The phenomenon, occurring in vitro or in vivo, of antibody combining with antigen of the type that stimulated the formation of the antibody, thereby resulting in agglutination, precipitation, complement fixation, greater susceptibility to ingestion and destruction by phagocytes, or neutralization of exotoxin. See: skin test. (05 Mar 2000) |
| antigen-binding site | <immunology> In immune network theory, an idiotope, an antigenic site of an antibody that is responsible for that antibody binding to an antigenic determinant (epitope). Also used of the site on a ligand molecule to which a cell surface receptor binds. (18 Nov 1997) |
| antigen-combining site | See: paratope. (05 Mar 2000) |
| antigen excess | In a precipitation test, the presence of uncombined antigen above that required to combine with all of the antibody; precipitation may be inhibited because the presence of excess antigen gives rise to soluble antigen-antibody complexes, in vivo the resultant antigen-antibody interaction in such an antigen excess may give rise to immune complexes, which have a potential to induce cellular damage; such injury underlies the pathologic changes seen in certain immune complex diseases. (05 Mar 2000) |
| antigen interferon | <cytokine> Interferon elaborated by T lymphocytes in response to either specific antigen or mitogenic stimulation. This type II interferon can be produced by recombinant DNA technology and is similar to the interferon secreted by lymphocytes and has antiviral and antineoplastic activity. Synonym: antigen interferon, immune interferon. Pharmacological action: antineoplastic agent, antiviral agents. (20 Sep 2002) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|